209 related articles for article (PubMed ID: 11943708)
21. Indomethacin induces differential expression of beta-catenin, gamma-catenin and T-cell factor target genes in human colorectal cancer cells.
Hawcroft G; D'Amico M; Albanese C; Markham AF; Pestell RG; Hull MA
Carcinogenesis; 2002 Jan; 23(1):107-14. PubMed ID: 11756231
[TBL] [Abstract][Full Text] [Related]
22. MSX2 is an oncogenic downstream target of activated WNT signaling in ovarian endometrioid adenocarcinoma.
Zhai Y; Iura A; Yeasmin S; Wiese AB; Wu R; Feng Y; Fearon ER; Cho KR
Oncogene; 2011 Oct; 30(40):4152-62. PubMed ID: 21499300
[TBL] [Abstract][Full Text] [Related]
23. Alterations of beta-catenin and Tcf-4 instead of GSK-3beta contribute to activation of Wnt pathway in hepatocellular carcinoma.
Cui J; Zhou X; Liu Y; Tang Z; Romeih M
Chin Med J (Engl); 2003 Dec; 116(12):1885-92. PubMed ID: 14687479
[TBL] [Abstract][Full Text] [Related]
24. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation.
Esufali S; Bapat B
Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999
[TBL] [Abstract][Full Text] [Related]
25. IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf.
Albanese C; Wu K; D'Amico M; Jarrett C; Joyce D; Hughes J; Hulit J; Sakamaki T; Fu M; Ben-Ze'ev A; Bromberg JF; Lamberti C; Verma U; Gaynor RB; Byers SW; Pestell RG
Mol Biol Cell; 2003 Feb; 14(2):585-99. PubMed ID: 12589056
[TBL] [Abstract][Full Text] [Related]
26. Activation of Wnt/beta-catenin/Tcf signaling in mouse skin carcinogenesis.
Bhatia N; Spiegelman VS
Mol Carcinog; 2005 Apr; 42(4):213-21. PubMed ID: 15765534
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of human pituitary tumor transforming gene (hPTTG), is regulated by beta-catenin /TCF pathway in human esophageal squamous cell carcinoma.
Zhou C; Liu S; Zhou X; Xue L; Quan L; Lu N; Zhang G; Bai J; Wang Y; Liu Z; Zhan Q; Zhu H; Xu N
Int J Cancer; 2005 Mar; 113(6):891-8. PubMed ID: 15514942
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of poly(ADP-ribose) polymerase-1 (PARP-1) in the early stage of colorectal carcinogenesis.
Nosho K; Yamamoto H; Mikami M; Taniguchi H; Takahashi T; Adachi Y; Imamura A; Imai K; Shinomura Y
Eur J Cancer; 2006 Sep; 42(14):2374-81. PubMed ID: 16809031
[TBL] [Abstract][Full Text] [Related]
29. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma.
Shiina H; Igawa M; Breault J; Ribeiro-Filho L; Pookot D; Urakami S; Terashima M; Deguchi M; Yamanaka M; Shirai M; Kaneuchi M; Kane CJ; Dahiya R
Clin Cancer Res; 2003 Jun; 9(6):2121-32. PubMed ID: 12796377
[TBL] [Abstract][Full Text] [Related]
30. Id2 is a target of the beta-catenin/T cell factor pathway in colon carcinoma.
Rockman SP; Currie SA; Ciavarella M; Vincan E; Dow C; Thomas RJ; Phillips WA
J Biol Chem; 2001 Nov; 276(48):45113-9. PubMed ID: 11572874
[TBL] [Abstract][Full Text] [Related]
31. beta-catenin nuclear expression correlates with cyclin D1 overexpression in sporadic desmoid tumours.
Saito T; Oda Y; Tanaka K; Matsuda S; Tamiya S; Iwamoto Y; Tsuneyoshi M
J Pathol; 2001 Sep; 195(2):222-8. PubMed ID: 11592102
[TBL] [Abstract][Full Text] [Related]
32. Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features.
Odajima T; Sasaki Y; Tanaka N; Kato-Mori Y; Asanuma H; Ikeda T; Satoh M; Hiratsuka H; Tokino T; Sawada N
Hum Pathol; 2005 Mar; 36(3):234-41. PubMed ID: 15791567
[TBL] [Abstract][Full Text] [Related]
33. Expression and significance of Wnt signaling components and their target genes in breast carcinoma.
He Y; Liu Z; Qiao C; Xu M; Yu J; Li G
Mol Med Rep; 2014 Jan; 9(1):137-43. PubMed ID: 24190141
[TBL] [Abstract][Full Text] [Related]
34. beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer.
Brabletz T; Jung A; Dag S; Hlubek F; Kirchner T
Am J Pathol; 1999 Oct; 155(4):1033-8. PubMed ID: 10514384
[TBL] [Abstract][Full Text] [Related]
35. Interrelation between expression of matrix metalloproteinase 7 and beta-catenin in esophageal cancer.
Saeki H; Tanaka S; Sugimachi K; Kimura Y; Miyazaki M; Ohga T; Sugimachi K
Dig Dis Sci; 2002 Dec; 47(12):2738-42. PubMed ID: 12498294
[TBL] [Abstract][Full Text] [Related]
36. Gastrin is a target of the beta-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis.
Koh TJ; Bulitta CJ; Fleming JV; Dockray GJ; Varro A; Wang TC
J Clin Invest; 2000 Aug; 106(4):533-9. PubMed ID: 10953028
[TBL] [Abstract][Full Text] [Related]
37. beta-catenin signaling and cancer.
Morin PJ
Bioessays; 1999 Dec; 21(12):1021-30. PubMed ID: 10580987
[TBL] [Abstract][Full Text] [Related]
38. Frequent deletions and mutations of the beta-catenin gene are associated with overexpression of cyclin D1 and fibronectin and poorly differentiated histology in childhood hepatoblastoma.
Takayasu H; Horie H; Hiyama E; Matsunaga T; Hayashi Y; Watanabe Y; Suita S; Kaneko M; Sasaki F; Hashizume K; Ozaki T; Furuuchi K; Tada M; Ohnuma N; Nakagawara A
Clin Cancer Res; 2001 Apr; 7(4):901-8. PubMed ID: 11309340
[TBL] [Abstract][Full Text] [Related]
39. beta-catenin mutation and expression analysis in ovarian cancer: exon 3 mutations and nuclear translocation in 16% of endometrioid tumours.
Wright K; Wilson P; Morland S; Campbell I; Walsh M; Hurst T; Ward B; Cummings M; Chenevix-Trench G
Int J Cancer; 1999 Aug; 82(5):625-9. PubMed ID: 10417756
[TBL] [Abstract][Full Text] [Related]
40. Role of a BCL9-related beta-catenin-binding protein, B9L, in tumorigenesis induced by aberrant activation of Wnt signaling.
Adachi S; Jigami T; Yasui T; Nakano T; Ohwada S; Omori Y; Sugano S; Ohkawara B; Shibuya H; Nakamura T; Akiyama T
Cancer Res; 2004 Dec; 64(23):8496-501. PubMed ID: 15574752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
